26295

Can Alfacalcidol ameliorate Atorvastatin-induced myopathy in adult male rats? A histological study

Article

Last updated: 01 Jan 2025

Subjects

-

Tags

-

Abstract

ABSTRACT
Introduction: Atorvastatin (Ator), is the treatment of choice for reducing blood cholesterol. Most adverse effects associated
with Statins therapy are muscle-related. Alfacalcidol (ALF), a vitamin D analog commonly used in osteoporosis; showed
beneficial effects beyond the skeleton including muscle.
Aim of the work: Investigating the possible protective effect of ALF in Atorvastatin induced myopathy in rats.
Materials and Methods: Twenty-one adult male albino rats were divided equally into 3 groups: Group I (control). Group
ΙΙ (Ator): received Atorvastatin (10 mg/kg/day). Group ΙΙΙ (Ator-ALF): received Ator concomitantly with Alfacalcidol
(0.5 μg/kg/day). After 4 weeks of daily oral medications administration, blood samples from all rats were analyzed for creatine
phosphokinase (CPK). The middle parts of biceps femoris muscles were processed for paraffin blocks for Hematoxylin and
Eosin stain and cytochrome C immunohistochemical stain that subjected to morphometric and statistical studies. Moreover,
resin blocks were processed for semithin and ultrathin sections examination.
Results: In group II, light microscopic examination revealed fragmented and tapered muscle fibers, in addition to loss of
regular pattern of transverse striation. Many fibers in transverse section acquired an irregular outline. Statistically, elevated
CPK level, decreased mean muscle fiber diameter and increased mean area % of cytochrome C immunoreactivity compared
to the control were recorded. Electron microscopic examination showed dissolution of many myofibrils and mitochondria
either disfigured giant or with destructed cristae. However, group III showed muscle fibers that are almost comparable to the
control group with clear transverse striations. That is confirmed statistically by decreased CPK level, increased mean muscle
fiber diameter and decreased mean area % of cytochrome C immunoreactivity versus group II. While ultrastructurally, few
areas of myofibrillar dissolution were noted.
Conclusion: Alfacalcidiol has a protective effect on Ator induced myopathy confirmed by the biochemical analysis, light and
electron microscopic examination as well as via morphometric studies.

DOI

10.21608/EJH.2019.25409

Authors

First Name

Dalia

Last Name

El-Deeb

MiddleName

Fathy

Affiliation

Department of Histology, Faculty of Medicine, Cairo University, Cairo, Egypt.

Email

-

City

-

Orcid

-

First Name

Mira

Last Name

Youssef

MiddleName

Farouk

Affiliation

Department of Histology, Faculty of Medicine, Cairo University, Cairo, Egypt.

Email

-

City

-

Orcid

-

First Name

Marwa

Last Name

Yousry

MiddleName

Mohamed

Affiliation

Department of Histology, Faculty of Medicine, Cairo University, Cairo, Egypt.

Email

mero.osman@yahoo.com

City

-

Orcid

-

First Name

Amy

Last Name

Ahmed

MiddleName

Mohamed

Affiliation

Department of Histology, Faculty of Medicine, Cairo University, Cairo, Egypt.

Email

-

City

-

Orcid

-

Volume

41

Article Issue

3

Related Issue

4737

Issue Date

2018-09-01

Receive Date

2019-01-31

Publish Date

2018-09-01

Page Start

285

Page End

299

Print ISSN

1110-0559

Online ISSN

2090-2417

Link

https://ejh.journals.ekb.eg/article_26295.html

Detail API

https://ejh.journals.ekb.eg/service?article_code=26295

Order

5

Type

Original Article

Type Code

119

Publication Type

Journal

Publication Title

Egyptian Journal of Histology

Publication Link

https://ejh.journals.ekb.eg/

MainTitle

Can Alfacalcidol ameliorate Atorvastatin-induced myopathy in adult male rats? A histological study

Details

Type

Article

Created At

22 Jan 2023